Early arteriovenous fistula (AVF) creation is generally considered to be the best strategy when planning a vascular access for haemodialysis (HD). However, new data suggest that very early AVF ...

August 6, 2010 — Patients with end-stage renal disease (ESRD) who live in poorer parts of the United States are less likely to receive an arteriovenous fistula (AVF) for hemodialysis vascular access ...

In a nationwide study, one fifth of surgeons had high AVG use rates, exceeding the guidelines threshold of 34%. The Centers for Medicare and Medicaid established an arteriovenous fistula (AVF) ...

Rates of arteriovenous fistula (AVF) placement in patients approaching hemodialysis in the United States are significantly lower in metropolitan than micropolitan areas, researchers reported online ...

Owing to the overall poor medical health of patients with end-stage renal disease, we have sought alternatives to the use of general anesthesia for access procedures. Furthermore, since local ...

Please provide your email address to receive an email when new articles are posted on . Published findings indicated that while patients 77 years or older had lower likelihoods of arteriovenous ...

Please provide your email address to receive an email when new articles are posted on . For older patients who initiated hemodialysis without permanent access, those with arteriovenous fistula ...

Pervasis Therapeutics Announces Promising Efficacy Results from Phase 1 and 2 Clinical Trials of Vascugel® in Dialysis Patients Needing Permanent AV Access, Data Builds on Compelling Safety Findings ...

A new healthcare analysis shows that a catheter-based endovascular system for creating hemodialysis access offers significant quality-of-life benefits and cost savings compared to the traditional ...

WALTHAM, Mass., Jan. 4, 2013 /PRNewswire/ -- Proteon Therapeutics, Inc., a private biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of ...